vimarsana.com

Page 16 - தொழிற்சங்கம் ஆரோக்கியம் அமைச்சர் கடுமையான News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Union Health Minister Harsh Vardhan nominated to Board of Global Alliance for Vaccines and Immunisation

Updated Dec 29, 2020 | 21:19 IST Vardhan will be representing the South East Area Regional Office (SEARO)/ Western Pacific Regional Office (WPRO) constituency on the GAVI Board. Union Health Minister Harsh Vardhan. | File photo  New Delhi: Union Health Minister Dr Harsh Vardhan has been nominated by the Global Alliance for Vaccines and Immunisation (GAVI) as a member on the GAVI Board, according to the Ministry of Health and Family Welfare. Vardhan will be representing the South East Area Regional Office (SEARO)/ Western Pacific Regional Office (WPRO) constituency on the GAVI Board. The seat is currently held by Myint Htwe of Myanmar. Vardhan will be representing India from January 1, 2021 until December 31, 2023.

India s first fully indigenous pneumococcal vaccine launched

India s first fully indigenous pneumococcal vaccine launched IANS   Pune-based Serum Institute of India, the largest vaccine manufacturer in the world by doses, on Monday announced the launch of India s first indigenously developed pneumococcalvaccine Pneumosil in the presence of Union Health Minister Harsh Vardhan. Pneumosil has been developed through collaboration spanning over a decade among the Serum Institute, PATH and the Bill and Melinda Gates Foundation. This significant milestone is aimed at improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low-and middle-income countries.   The vaccine will provide effective and long-lasting protection for children against pneumococcal diseases. The vaccine makes the Serum Institute the world s third supplier of pneumococcal conjugate vaccines (PCV) under the pneumococcal Advance Market Commitment (AMC), and the first developing country vaccine manufacturer to access the global PCV

India launches first fully indigenous pneumococcal vaccine

India launches first fully indigenous pneumococcal vaccine Filed on December 28, 2020 Alamy Serum Institute is also testing and producing the Oxford-AstraZeneca Covid-19 vaccine in India Pune-based Serum Institute of India, the largest vaccine manufacturer in the world by doses, on Monday announced the launch of India s first indigenously developed pneumococcal vaccine - Pneumosil - in the presence of Union Health Minister Harsh Vardhan. Pneumosil has been developed through collaboration spanning over a decade among the Serum Institute, PATH and the Bill and Melinda Gates Foundation. This significant milestone is aimed at improving pneumococcal conjugate vaccine affordability and enabling sustainable access for low-and middle-income countries.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.